Ann: Receipt of R&D Tax Incentive, page-17

Well, best of luck mate. 

Will say that valuation was before the legal cost threat though.

POH needs a bit of time so maybe SIAC will do its normal thing and take forever to hand down its decision. 

Where is the main part of POH's business these days? Animal or human?  Could POH (just an example) try and sell off its animal business and concentrate purely on the Human business? That could give it a way chest and allow funds to fast track research.

That would limit its options as well.